Dual antiplatelet therapy and the risk of bleeding.

Ziegelstein, Roy C; Green, Ariel; Sauder, Michael

Ziegelstein, Roy C; Green, Ariel; Sauder, Michael.

Arch Intern Med ; 171(8): 787; reply 787-8, 2011 Apr 25.

Article in En | MEDLINE | ID: mdl-21518951

Subject(s)

Aspirin/adverse effects; Hemorrhage/chemically induced; Platelet Aggregation Inhibitors/adverse effects; Ticlopidine/analogs & derivatives; Warfarin/adverse effects; Aspirin/administration & dosage; Atrial Fibrillation/complications; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors/administration & dosage; Risk Assessment; Risk Factors; Thrombosis/etiology; Thrombosis/prevention & control; Ticlopidine/administration & dosage; Ticlopidine/adverse effects; Warfarin/administration & dosage

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Warfarin / Ticlopidine / Platelet Aggregation Inhibitors / Aspirin / Hemorrhage Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Arch Intern Med Year: 2011 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google